2017 Press Releases

Date Title  
Toggle Summary West Pharmaceutical Services Files IND Application For Nasal Leuprolide For The Treatment Of Endometriosis
LIONVILLE, Pa., Jan. 31 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that it completed filling of an Investigational New Drug (IND) application covering a nasally administered formulation of leuprolide for the treatment of endometriosis and other selected
West Pharmaceutical Services Files IND Application For Nasal Leuprolide For The Treatment Of Endometriosis
LIONVILLE, Pa., Jan. 31 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that it completed filling of an Investigational New Drug (IND) application covering a nasally administered formulation of leuprolide for the treatment of endometriosis and other selected
Toggle Summary West Pharmaceutical Services to Commence Phase I Clinical Trials for Nasal Morphine for Pain
LIONVILLE, Pa., Jan. 18 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that its December 1999 IND (Investigational New Drug) application for a nasally administered formulation of morphine has now passed the FDA 30 day comment period, clearing the way for
West Pharmaceutical Services to Commence Phase I Clinical Trials for Nasal Morphine for Pain
LIONVILLE, Pa., Jan. 18 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that its December 1999 IND (Investigational New Drug) application for a nasally administered formulation of morphine has now passed the FDA 30 day comment period, clearing the way for